The Council for the Indian School Certificate Examinations (CISCE) has released the ISC Computer Science (Subject Code - 868) for the Year 2027 evaluation cycle. It is designed specifically to make ...
6d
Recursion Pharmaceuticals vs. Summit Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
Recursion harnesses AI for large-scale drug discovery, while Summit's betting on a single oncology candidate. How do their ...
Mirendil, founded by two ex-Anthropic researchers, raised $200M at a $1bn valuation to sell self-improving AI research to everyone.
Don't worry, this post is spoiler-free.
Blake Crouch wrote a popular science-fiction thriller novel that is just screaming for a Hollywood adaptation. So, what's the ...
Google DeepMind CEO Demis Hassabis warns humanity is on the cusp of Artificial General Intelligence, potentially within four years, urging immediate preparation. He views current AI agents as a ...
AI educator and founder of The Cutting Edge Group, Ansh Mehra lauded Anthropic's initiative and said tech companies should agree to a self-imposed global pause on LLM (large language model) releases ...
Recursive Superintelligence has raised $650 million at a $4.65 billion valuation in a funding round led by GV and Greycroft, according to the company. The round also included participation from AMD ...
Recursive Superintelligence Inc., a startup that hopes to develop self-improving artificial intelligence models, launched today with $650 million in funding. Alphabet Inc.’s GV fund and Greycroft led ...
Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the best AI stocks under $50 to buy right now. On May 6, Recursion reported significant progress across its AI-driven clinical pipeline for Q1 ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. logos of OpenAI There’s interesting news coming from Sam Altman’s empire, a firm known for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results